Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Rekvina Laboratories Ltd (NSE: VINRKLB), ISIN INE092O01028 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
VINRKLB last traded at ₹51.94 (-2.00%), with a 52-week range of ₹6.75 to ₹59.40 (as of 23 Sep 2026).
Shareholding as of Dec 2025: promoters 41.30%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
Data sourced from NSE and BSE filings. Educational — not investment advice.